0001638599-17-000342.txt : 20170405 0001638599-17-000342.hdr.sgml : 20170405 20170405160111 ACCESSION NUMBER: 0001638599-17-000342 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140905 FILED AS OF DATE: 20170405 DATE AS OF CHANGE: 20170405 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iBio, Inc. CENTRAL INDEX KEY: 0001420720 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262797813 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 9 INNOVATION WAY, SUITE 100 CITY: NEWARK STATE: DE ZIP: 19711 BUSINESS PHONE: 302 355-0650 MAIL ADDRESS: STREET 1: 9 INNOVATION WAY, SUITE 100 CITY: NEWARK STATE: DE ZIP: 19711 FORMER COMPANY: FORMER CONFORMED NAME: iBioPharma, Inc. DATE OF NAME CHANGE: 20080806 FORMER COMPANY: FORMER CONFORMED NAME: InB:Biotechnologies, Inc. DATE OF NAME CHANGE: 20071210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chang Glenn CENTRAL INDEX KEY: 0001384967 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35023 FILM NUMBER: 17742538 MAIL ADDRESS: STREET 1: C/O IBIO, INC. STREET 2: 9 INNOVATION WAY, SUITE 100 CITY: NEWARK STATE: DE ZIP: 19711 4 1 doc4_4650.xml PRIMARY DOCUMENT X0306 4 2014-09-05 0 0001420720 iBio, Inc. IBIO 0001384967 Chang Glenn C/O IBIO, INC. 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022 1 0 0 0 Stock Option (right to buy) 0.49 2014-09-05 4 A 0 60000 0.49 A 2024-09-05 Common Stock 60000 390000 D Stock Option (right to buy) 1.72 2015-09-04 4 A 0 100000 1.72 A 2025-09-04 Common Stock 100000 490000 D (1) Vesting starts 7/1/2014, in equal annual installments over three years. (2) Vesting starts 7/1/2015, in equal annual installments over year. /s/ Glenn Chang 2017-04-05